Be sure to search the FDA full digital library prior to making any requests for information
Using the pen Check and prepare Confirm the pen is in date and at the correct dose
Nausea, diarrhea, vomiting, constipation, abdominal pain, decreased appetite, and fatigue occurring in 5% of participants in clinical trials, mostly mild-to-moderate and peaking during dose escalation
Vitamin B12, also called cobalamin, is part of the B-complex vitamins
Second generation GLP-1 receptor agonists that were developed have more similarity with human GLP-1 and are linked to larger carrier molecules to limit renal elimination
Constipation prevention through diet Constipation affects roughly 10-15% of GLP-1 users and can become severe enough to require medical attention